Abul Kalam Najmi
Abul Kalam Najmi publishes mostly in Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, on topics such as Alzheimer's disease research and treatments, Diabetes Treatment and Management and Natural Antidiabetic Agents Studies.
- World rank
- #918,759 of 7,710,434 ranked researchers
- Rank in India
- #12,623 of 280,097
- Works
- 285
- Citations
- 7.4k
- Citations per work
- 26.1
What does Abul Kalam Najmi research?
Abul Kalam Najmi's work is mostly in Medicine (28%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else17561.5%
- Health Sciences7927.6%
- Medicine7927.6%
- Life Sciences3110.9%
- 1Molecular Biology11% of their works
- 2Cardiology and Cardiovascular Medicine7% of their works
- 3Endocrinology, Diabetes and Metabolism6% of their works
- 4Physiology5% of their works
- 5Complementary and alternative medicine5% of their works
- 6Pathology and Forensic Medicine5% of their works
Research topics
- Alzheimer's disease research and treatments
- Diabetes Treatment and Management
- Natural Antidiabetic Agents Studies
- Chemotherapy-induced organ toxicity mitigation
- Pharmacological Effects of Natural Compounds
- Chemotherapy-induced cardiotoxicity and mitigation
- Nigella sativa pharmacological applications
- Advancements in Transdermal Drug Delivery
Which keywords describe Abul Kalam Najmi's research?
The keywords of their largest research topics: Oxidative Stress, Type 2 Diabetes, Antioxidants, Chemotherapy, Inflammation, Antioxidant, Cancer and Amyloid Hypothesis.
- Microneedles
- Nigella sativa
- Glycyrrhizin
- Anthracyclines
- Cisplatin
- Glucose Control
- Cardiovascular Outcomes
- Amyloid Hypothesis
- Antioxidant
- Chemotherapy
- Type 2 Diabetes
- Oxidative Stress
- Antioxidants
- Inflammation
- Cancer
- Tau Pathology
- Diabetes
- Insulin Resistance
- Nephrotoxicity
- Doxorubicin
- Licorice
- Thymoquinone
- Solid Lipid Nanoparticles
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Oxidative Stress794 topics
- Type 2 Diabetes402 topics
- Antioxidants392 topics
- Chemotherapy352 topics
- Inflammation352 topics
- Antioxidant292 topics
- Cancer292 topics
- Amyloid Hypothesis241 topic
- Tau Pathology241 topic
- Cardiovascular Outcomes201 topic
- Diabetes201 topic
- Glucose Control201 topic
- Insulin Resistance201 topic
- Cisplatin191 topic
- Nephrotoxicity191 topic
- Anthracyclines161 topic
- Doxorubicin161 topic
- Glycyrrhizin161 topic
- Licorice161 topic
- Nigella sativa131 topic
- Thymoquinone131 topic
- Microneedles101 topic
- Solid Lipid Nanoparticles101 topic
Where does Abul Kalam Najmi work?
Abul Kalam Najmi's main affiliation in the publication record is Jamia Hamdard, India.
How many publications and citations does Abul Kalam Najmi have?
OpenAlex counts 285 works and 7,428 citations for Abul Kalam Najmi, an h-index of 44, ranking #918,759 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Abul Kalam Najmi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.